Biologically created drugs are the biggest cost for public health plans like B.C. Pharmacare. (Flickr)

B.C. Pharmacare expanding use of ‘biosimilar’ drugs to save money

Europe far ahead of Canada in adopting alternative treatments

Bioengineered drugs for conditions such as diabetes and arthritis are the most expensive part of B.C.’s Pharmacare and other public drug plans, and new alternatives are being introduced.

The shift began Monday with the introduction of a diabetes drug called Jardiance, and a psoriatic arthritis drug called Talz. Coverage is also enhanced for arthritis treatments including certolizumab, leflunomide, rituximab, tocilizumab and tofacitinab.

A list of affected drug treatments can be found here.

The change is expected to save the province $96 million over the first three years, Health Minister Adrian Dix said. B.C. is following the lead of Europe in moving to alternative drugs, replacing patented treatments made from biological sources such as yeasts.

Medical experts say “biosimilars” are genetically as identical as these types of drugs can be. Affected patients in B.C. will be given a six-month transition period with their doctors to introduce the alternative treatments and identify exceptions.

“Biosimilars are a necessary step to ensure Pharmacare coverage provides existing coverage for more people and fund new drugs well into the future,” Dix said.

Cheryl Koehn, president of Arthritis Consumer Experts who has been living with rheumatoid arthritis for decades, said she works with people struggling to get reimbursement for medications recommended by their rheumatologists.

“Today’s announcement is a direct answer to this problem, clinically and financially,” Koehn said. “It ensures continued reimbursement coverage for British Columbians who transition to the next-generation biologic and ensures that reimbursement for other patents becomes available.”

Dr. Tom Elliott, medical director of B.C. Diabetes, said extending coverage for Jardiance for Type 2 diabetes is financed by savings from using insulin glargine biosimilar Basaglar in place of the biologic Lantus.

“This change will entail some inconvenience and require some adaptation for the tens of thousands of British Columbians currently using Lantus and their prescribing physicians,” Elliott said. “Patients and prescribers can rest assured that Basaglar has the same effectiveness and time release pattern, unit for unit, as Lantus.”


@tomfletcherbc
tfletcher@blackpress.ca

Like us on Facebook and follow us on Twitter.

Just Posted

Leafs lose marathon season opener

Nelson fell 3-2 to Fernie in double overtime

Latest round of Columbia River Treaty talks wrap up in Cranbrook

Federal, provincial, U.S. and Indigenous representatives recently met for eight round of discussions

CHECK THIS OUT: Libraries as safe spaces for the homeless

Anne DeGrace writes about an upcoming movie and talk focused on libraries and homelessness

First Nations given max compensation for Ottawa’s child-welfare discrimination

2016 ruling said feds didn’t give same funding for on-reserve kids as was given to off-reserve kids

PLACE NAMES: Kaslo and Sandon neighbourhoods

Narrow valley saw Sandon’s main street over a creek

VIDEO: Vancouver Island mayor details emergency response after fatal bus crash

Sharie Minions says she is ‘appalled’ by condition of road where bus crashed

Conservatives promise tax cut that they say will address Liberal increases

Scheer says the cut would apply to the lowest income bracket

B.C. VIEWS: Cutting wood waste produces some bleeding

Value-added industry slowly grows as big sawmills close

Fewer trees, higher costs blamed for devastating downturn in B.C. forestry

Some say the high cost of logs is the major cause of the industry’s decline in B.C.

Federal food safety watchdog says batch of baby formula recalled

The agency says it’s conducting a food safety investigation

UVic president offers condolences after two students killed in bus crash

‘We also grieve with those closest to these members of our campus community,’ Cassels says

Coming Home: B.C. fire chief and disaster dog return from hurricane-ravaged Bahamas

The pair spent roughly one week on Great Abaco Island assisting in relief efforts

Newcomer Ferland lines up with sniper Pettersson as Vancouver Canucks camp opens

Ferland provides more depth and a scoring threat up front, Pettersson says

Intelligence official charged seemed to be ‘exemplar of discretion’: UBC professor

Professor Paul Evans says he served on Cameron Ortis’s doctoral dissertation committee

Most Read